| Dr Amilcar Gabriel Rodriguez Melendez, MD | |
|
917 Ave. Tito Castro Suite 802, Torre Medica San Lucas, Ponce, PR 00716 | |
| (787) 505-4555 | |
| (787) 507-4555 |
| Full Name | Dr Amilcar Gabriel Rodriguez Melendez |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 13 Years |
| Location | 917 Ave. Tito Castro Suite 802, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174817449 | NPI | - | NPPES |
| Entity Name | Amilcar Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003690272 PECOS PAC ID: 8123473725 Enrollment ID: O20231018000003 |
News Archive
Responding to an opinion piece published in Nature Medicine last week in which Tikki Pang, a visiting professor at the National University of Singapore and former director of research policy and cooperation at the WHO, and Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, argue the case for reforming and improving the WHO, KPLU's Tom Paulson writes in a post on KPLU 88.5's "Humanosphere" blog.
The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer, report researchers from the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter.
Over the last year, it's been rare to utter the word "stent" without at least thinking "thrombosis," an uncommon but serious complication that's been on the minds of interventional cardiologists and patients alike.
Physicians are anticipating the arrival of new oral therapies for multiple sclerosis patients, with initial research showing very high awareness of oral candidates, particularly Novartis' Gilenya, which received FDA approval for relapsing forms of the disease in late September. The majority of neurologists expect Gilenya to be very useful as a therapy and trial of the drug is predicted to be strong, according to new research by GfK HealthCare.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amilcar Gabriel Rodriguez Melendez, MD Po Box 8430, Ponce, PR 00732-8430 Ph: (787) 505-4555 | Dr Amilcar Gabriel Rodriguez Melendez, MD 917 Ave. Tito Castro Suite 802, Torre Medica San Lucas, Ponce, PR 00716 Ph: (787) 505-4555 |
News Archive
Responding to an opinion piece published in Nature Medicine last week in which Tikki Pang, a visiting professor at the National University of Singapore and former director of research policy and cooperation at the WHO, and Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, argue the case for reforming and improving the WHO, KPLU's Tom Paulson writes in a post on KPLU 88.5's "Humanosphere" blog.
The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer, report researchers from the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter.
Over the last year, it's been rare to utter the word "stent" without at least thinking "thrombosis," an uncommon but serious complication that's been on the minds of interventional cardiologists and patients alike.
Physicians are anticipating the arrival of new oral therapies for multiple sclerosis patients, with initial research showing very high awareness of oral candidates, particularly Novartis' Gilenya, which received FDA approval for relapsing forms of the disease in late September. The majority of neurologists expect Gilenya to be very useful as a therapy and trial of the drug is predicted to be strong, according to new research by GfK HealthCare.
› Verified 4 days ago
Dr. Jaime R Villa Colon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2225 Ponce Bypass, Parra Building 403, Ponce, PR 00717 Phone: 787-259-3391 Fax: 787-259-8474 | |
Pedro Vendrell, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2431 Blvd Luis A Ferre Ste 104, Ponce, PR 00717 Phone: 787-290-0141 Fax: 787-290-0121 |